Concepedia

Pravin T. P. Kaumaya

PT

Statistics

Publications

43

Citations

2.1K

H-Index

30

Active since

1984

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

The Ohio State University Wexner Medical Center

Northwestern University

Emory University

Pravin T. P. Kaumaya is an author at The Ohio State University specializing in immunology, life sciences, and cancer immunotherapy.

ORCID

Publications per year

1984–2022

43

Publications

43

The EBV-Encoded dUTPase Activates NF-κB through the TLR2 and MyD88-Dependent Signaling Pathway

Maria-Eugenia Ariza, Ronald Glaser, Pravin T. P. Kaumaya et al. · The Journal of Immunology · 2009 · 150 citations · Full text

, , +17

Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.

Naveen Dakappagari, Davina Douglas, Pierre L. Triozzi et al. · PubMed · 2000 · 113 citations

, , +17

Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla

Lauren O. Bakaletz, Edward R. Leake, John M. Billy et al. · Vaccine · 1997 · 84 citations

, , +17

Phase I Active Immunotherapy With Combination of Two Chimeric, Human Epidermal Growth Factor Receptor 2, B-Cell Epitopes Fused to a Promiscuous T-Cell Epitope in Patients With Metastatic and/or Recurrent Solid Tumors

Pravin T. P. Kaumaya, Kevin Foy, Joan T. Garrett et al. · Journal of Clinical Oncology · 2009 · 84 citations · Full text

, , +17

A Chimeric Multi-Human Epidermal Growth Factor Receptor-2 B Cell Epitope Peptide Vaccine Mediates Superior Antitumor Responses

Naveen Dakappagari, John Pyles, Robin Parihar et al. · The Journal of Immunology · 2003 · 75 citations

, , +17

1–5 of 43